Traweek ST, Liu J and H Battifora (1993) Keratin gene expression in non-epithelial tissues. Am JPathol 142: [1111] [1112] [1113] [1114] [1115] [1116] [1117] [1118] Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer -reply Sir We agree that K19 mRNA is detectable in normal lymph nodes (from patients without any epithelial malignancy) by reverse transcription polymerase chain reaction (RT-PCR) after many cycles of amplification. In our paper (Schoenfeld et al, 1994) , we described the methodology and demonstrated a 'cut-off' of 40 cycles of amplification beneath which all normal lymph nodes remained negative for K19 mRNA; those above this level may be taken to indicate lymph node metastases. In our studies, this 'cutoff' occurred after 40 cycles of RT-PCR and Southern hybridization.
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A second amplification, using nested primers, resulted in the appearance of mRNA-derived K19 product in normal nodes as well as nodes from cancer patients. Thus, there is a low level of K19 mRNA in normal nodes, and the potential of RT-PCR in the staging of breast cancer is therefore limited by the specificity of the tumour marker.
Mutations at codon 974 of the DPYD gene are a rare event
Sir
We regret to inform you of an error made in a recently published article in the British Journal of . 'Mutations at codon 974 of the DPYD gene are -a rare event' from Ridge et al (1997) . In this study, Ridge et al attempted to determine the frequency of a mutation originally described by our laboratory in 1995 (abstract presented at the American Association of Cancer Research, AACR). Unfortunately, the authors of this study misin- After a careful review of this article, we have determined that Ridge et al assigned the first adenosine nucleotide in the initiating methionine as the number 1 position. This resulted in the incorrect assignment of codon 974 as the site of the mutation (Figure 1 ). We concur with Ridge et al that the frequency of this mutation should be determined in the population and will therefore forward a copy of this letter to Ridge et al, along with an offer to provide any information necessary to correct this study. Figure 1 The bovine primer (bold and underlined) used to PCR amplify the 5' end of human lymphocyte DPD cDNA. The original numbering system assigned the 5' end of the bovine primer as the number 1 position, with the mutation ultimately corresponding to position 2921, as originally presented in the abstract. Ridge et al (1997) assigned the first adenosine nucleotide in the initiating methionine as the number 1 position and therefore localized the mutation to the wrong codon (974 instead of 949)
